Transcription regulation of MYB: a potential and novel therapeutic target in cancer

Area of Science:

• Molecular Biology
• Cancer Research
• Drug Discovery

Background:

• Transcription factors play crucial roles in gene expression and disease progression.
• They have been historically overlooked as direct drug targets.
• Understanding their regulatory mechanisms is key to novel therapeutic strategies.

Purpose of the Study:

• To review the potential of targeting regulatory mechanisms controlling gene expression.
• To explore strategies for targeting transcription factor regulation in cancer drug discovery.
• To highlight the role of c-MYB regulation in various cancers.

Main Methods:

• Review of existing literature on transcription factor regulation and cancer.
• Analysis of specific regulatory pathways for c-MYB in leukemia, breast cancer, and colorectal cancer.
• Discussion of potential therapeutic strategies targeting activators and co-activators.

Main Results:

• c-MYB's critical role in multiple cancer types is established.
• Specific regulatory mechanisms involving MLL-fusion protein, estrogen receptor (ER), and NF-κB influence c-MYB transcription.
• Targeting these regulators offers potential therapeutic avenues.

Conclusions:

• Targeting regulatory mechanisms of transcription factors, like c-MYB, presents a novel approach for cancer drug discovery.
• Cancer-specific strategies can be developed by focusing on key activators and co-activators.
• This approach offers a promising alternative to directly targeting transcription factors.